← 產業報告目錄
Companion Animal Medicine Market Size, Share & Trends Analysis Report By Animal Type (dogs, cats, horses and others), Product (Biologics, Pharmaceuticals and Medicated Feed Additives), Distribution Channel (Retail, E-commerce, Hospital Pharmacy), And Indication (Infectious Diseases, Dermatologic Diseases, Pain, Orthopedic Diseases, Behavioral Diseases, Other Indications), By Region, And Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-09頁數 180報告編號 INSIGHTACE-4b2f5f1194
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
With a 2024 valuation of USD 22.2 billion, the global Companion Animal Medicine Market is projected to increase to USD 54.5 billion by 2034, demonstrating a CAGR of 9.5% during the 2025–2034 forecast window.
Companion Animal Medicine covers key industry insights & findings from the report:
The industry is driven by improvements in the availability of veterinary care and pet owners' willingness to pay for medical treatment. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
Market momentum is bolstered by mounting interest in advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
From a regional perspective, mature markets in North America and Europe continue to hold substantial shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and mounting investment in the sector.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Companion Animal Medicine Market Snapshot
Chapter 4. Global Companion Animal Medicine Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Animal Type Estimates & Trend Analysis
5.1. by Animal Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Animal Type:
5.2.1. Dogs
5.2.2. Cats
5.2.3. Horses
5.2.4. Others
Chapter 6. Market Segmentation 2: by Product Estimates & Trend Analysis
6.1. by Product & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Product:
6.2.1. Biologics
6.2.1.1. Vaccines
6.2.1.1.1. Attenuated Live Vaccines
6.2.1.1.2. Inactivated Vaccines
6.2.1.1.3. Recombinant Vaccines
6.2.1.1.4. Toxoid
6.2.1.1.5. Others
6.2.2. Pharmaceuticals
6.2.2.1. Parasiticides
6.2.2.2. Anti-infectives
6.2.2.3. Anti-inflammatory
6.2.2.4. Analgesics
6.2.2.5. Others
6.2.3. Medicated Feed Additives
Chapter 7. Market Segmentation 3: by Indication Estimates & Trend Analysis
7.1. by Indication & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Indication:
7.2.1. Infectious Diseases
7.2.2. Dermatologic Diseases
7.2.3. Pain
7.2.4. Orthopedic Diseases
7.2.5. Behavioral Diseases
7.2.6. Other Indications
Chapter 8. Market Segmentation 4: by Distribution Channel Estimates & Trend Analysis
8.1. by Distribution Channel & Market Share, 2024 & 2034
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Distribution Channel:
8.2.1. Retail
8.2.2. E-commerce
8.2.3. Hospital Pharmacy
Chapter 9. Companion Animal Medicine Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Companion Animal Medicine Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
9.1.2. North America Companion Animal Medicine Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.1.3. North America Companion Animal Medicine Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2021-2034
9.1.4. North America Companion Animal Medicine Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
9.1.5. North America Companion Animal Medicine Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.2. Europe
9.2.1. Europe Companion Animal Medicine Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
9.2.2. Europe Companion Animal Medicine Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.2.3. Europe Companion Animal Medicine Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2021-2034
9.2.4. Europe Companion Animal Medicine Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
9.2.5. Europe Companion Animal Medicine Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.3. Asia Pacific
9.3.1. Asia Pacific Companion Animal Medicine Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
9.3.2. Asia Pacific Companion Animal Medicine Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.3.3. Asia-Pacific Companion Animal Medicine Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2021-2034
9.3.4. Asia-Pacific Companion Animal Medicine Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
9.3.5. Asia Pacific Companion Animal Medicine Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.4. Latin America
9.4.1. Latin America Companion Animal Medicine Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
9.4.2. Latin America Companion Animal Medicine Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.4.3. Latin America Companion Animal Medicine Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2021-2034
9.4.4. Latin America Companion Animal Medicine Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
9.4.5. Latin America Companion Animal Medicine Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.5. Middle East & Africa
9.5.1. Middle East & Africa Companion Animal Medicine Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
9.5.2. Middle East & Africa Companion Animal Medicine Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.5.3. Middle East & Africa Companion Animal Medicine Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2021-2034
9.5.4. Middle East & Africa Companion Animal Medicine Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
9.5.5. Middle East & Africa Companion Animal Medicine Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Ashish Life Sciences Pvt Ltd (India)
10.2.2. Bimeda, Inc.
10.2.3. Biogénesis Bagó (US)
10.2.4. Boehringer Ingelheim International GmbH.
10.2.5. Brilliant Bio Pharma (India)
10.2.6. Calier
10.2.7. Ceva Sante Animale (France)
10.2.8. Chanelle Pharma (Ireland)
10.2.9. Dechra Pharmaceuticals PLC (UK)
10.2.10. Eco Animal Health Group Plc. (UK)
10.2.11. Elanco Animal Health Incorporated (US)
10.2.12. Endovac Animal Health (US)
10.2.13. HIPRA (Spain)
10.2.14. Indian Immunologicals Ltd (India)
10.2.15. Intas Pharmaceuticals (India)
10.2.16. Kyoritsu Seiyaku (Japan)
10.2.17. Lutim Pharma Pvt Ltd (India)
10.2.18. Merck & Co., Inc.
10.2.19. Neogen Corporation (US)
10.2.20. Norbrook Holdings Limited (UK)
10.2.21. Orion Group (Finland)
10.2.22. Tianjin Ringpu Bio-Technology Co Ltd. (China)
10.2.23. Vetindia Pharmaceuticals limited (India)
10.2.24. Vetoquinol S.A.;
10.2.25. Virbac
10.2.26. Zenex Animal Health India Private Limited (India)
10.2.27. Zoetis, Inc. (US)
10.2.28. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們